KDR and cancer: Other large oncolytic DNA viruses, such as the JX-594 poxvirus, expressing the granulocyte–macrophage colony-stimulating factor (GM-CSF) and designed to selectively replicate in cancer cells, yielded a superior effect when administered sequentially with sorafenib (a VEGFR inhibitor) in patients with hepatocellular carcinoma [148].